Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant advances » significant advantages (Expand Search), significantly advanced (Expand Search), significant advancements (Expand Search)
advances decrease » advanced disease (Expand Search), advanced defense (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant advances » significant advantages (Expand Search), significantly advanced (Expand Search), significant advancements (Expand Search)
advances decrease » advanced disease (Expand Search), advanced defense (Expand Search)
-
3621
-
3622
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3623
-
3624
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3625
-
3626
-
3627
-
3628
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3629
-
3630
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3631
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3632
-
3633
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3634
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
3635
-
3636
Potential metabolites in the colonic tissue related with diarrhea induced by FSE.
Published 2025Subjects: -
3637
-
3638
-
3639
Heatmap and pathway analysis of the potential metabolites in colon tissue related with diarrhea.
Published 2025Subjects: -
3640